Zobrazeno 1 - 10
of 23
pro vyhledávání: '"M. Germana Sanna"'
Autor:
Simone Mori, Shuei Sugama, William Nguyen, Tatiana Michel, M. Germana Sanna, Manuel Sanchez-Alavez, Rigo Cintron-Colon, Gianluca Moroncini, Yoshihiko Kakinuma, Pamela Maher, Bruno Conti
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-10 (2017)
Abstract Background The majority of Parkinson’s disease (PD) cases are sporadic and idiopathic suggesting that this neurodegenerative disorder is the result of both environmental and genetic factors. Stress and neuroinflammation are among the facto
Externí odkaz:
https://doaj.org/article/5950a5a111e644f3b24f9e96bcbaf71f
Autor:
Gianluca Moroncini, Pamela Maher, Tatiana Michel, William Nguyen, Simone Mori, Bruno Conti, Rigo Cintron-Colon, Yoshihiko Kakinuma, Shuei Sugama, Manuel Sanchez-Alavez, M. Germana Sanna
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-10 (2017)
Journal of Neuroinflammation
Journal of Neuroinflammation
The majority of Parkinson’s disease (PD) cases are sporadic and idiopathic suggesting that this neurodegenerative disorder is the result of both environmental and genetic factors. Stress and neuroinflammation are among the factors being investigate
Autor:
William B. Kiosses, Emanuela Repetto, Sean Riley, Yasushi Kohno, Stuart M. Cahalan, M. Germana Sanna, Joan Heller Brown, Andrew D. McCulloch, Nhan Nguyen, Pedro J. Gonzalez-Cabrera, Steven J. Brown, Nora B. Leaf, Lusine Abgaryan, Kevin P. Vincent, Hugh Rosen
Publikováno v:
Molecular pharmacology, vol 89, iss 1
Sanna, MG; Vincent, KP; Repetto, E; Nguyen, N; Brown, SJ; Abgaryan, L; et al.(2016). Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction. MOLECULAR PHARMACOLOGY, 89(1), 176-186. doi: 10.1124/mol.115.100222. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/19v1t1kw
Sanna, MG; Vincent, KP; Repetto, E; Nguyen, N; Brown, SJ; Abgaryan, L; et al.(2016). Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction. MOLECULAR PHARMACOLOGY, 89(1), 176-186. doi: 10.1124/mol.115.100222. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/19v1t1kw
The molecular pharmacology of the G protein-coupled receptors for sphingosine 1-phosphate (S1P) provides important insight into established and new therapeutic targets. A new, potent bitopic S1P3 antagonist, SPM-354, with in vivo activity, has been u
Autor:
Greg Reinhart, Gye Won Han, Hans Desale, M. Germana Sanna, Mark T. Griffith, Peter Kuhn, Bryan Clemons, Hugh Rosen, Stephan C. Schuerer, Raymond C. Stevens, Fiona Scott, Euijung Jo, Michael A. Hanson, Stuart M. Cahalan, Christopher B. Roth
Publikováno v:
Science. 335:851-855
A Lipid-Sensing GPCR Sphingosine 1-phosphate (S1P) is a sphingolipid that binds to the G protein–coupled receptor subtype 1 (S1P 1 ) to activate signaling pathways involved in regulation of the vascular and immune systems. Hanson et al. (p. 851 ) d
Autor:
Pedro J. Gonzalez-Cabrera, Stuart M. Cahalan, M. Germana Sanna, Anthony S. Don, David Marsolais, Hugh Rosen
Publikováno v:
Immunological Reviews. 223:221-235
Summary: Modulation of complex functions within the immune system has proven to be surprisingly sensitive to alterations in the lysophospholipid sphingosine 1-phosphate (S1P) receptor-ligand rheostat. This has become increasingly evident from both ch
Autor:
Pedro J. Gonzalez-Cabrera, Hugh Rosen, Ian Parker, Michael D. Cahalan, Chi-Huey Wong, M. Germana Sanna, Sindy H. Wei, Euijung Jo, David Marsolais, Sheng-Kai Wang, Wei-Chieh Cheng, Melanie P. Matheu, Anthony S. Don
Publikováno v:
Nature Chemical Biology. 2:434-441
Sphingosine 1-phosphate (S1P, 1) regulates vascular barrier and lymphoid development, as well as lymphocyte egress from lymphoid organs, by activating high-affinity S1P1 receptors. We used reversible chemical probes (i) to gain mechanistic insights i
Autor:
Hugh Rosen, M. Germana Sanna, Ian Parker, Sheng-Kai Wang, Melanie P. Matheu, Sindy H. Wei, Chi-Huey Wong, Euijung Jo, Michael D. Cahalan
Publikováno v:
Nature Immunology. 6:1228-1235
Sphingosine 1-phosphate type 1 (S1P(1)) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood. One hypothesis proposes that agonists act as 'functional antagonists' by binding and
Autor:
Pedro J. Gonzalez-Cabrera, Shobha Thangada, Daniel A. Osborne, Euijung Jo, Gabor Tigyi, M. Germana Sanna, Hugh Rosen, Abby L. Parrill, Timothy Hla
Publikováno v:
Chemistry & Biology. 12:703-715
Summary The essential role of the sphingosine 1-phosphate (S1P) receptor S1P 1 in regulating lymphocyte trafficking was demonstrated with the S1P 1 -selective nanomolar agonist, SEW2871. Despite its lack of charged headgroup, the tetraaromatic compou
Autor:
Quinn Deveraux, M. Germana Sanna, Betty Chuang, Jean da Silva Correia, Lorien M. Paulson, Ying Luo, Richard J. Ulevitch, Binh Nguyen
Publikováno v:
Journal of Biological Chemistry. 277:30454-30462
We have previously described a new aspect of the Inhibitor of Apoptosis (IAP) family of proteins anti-apoptotic activity that involves the TAK1/JNK1 signal transduction pathway (1,2). Our findings suggest the existence of a novel mechanism that regul
Autor:
Odile Ducrey, Richard J. Ulevitch, Jean da Silva Correia, Jongdae Lee, Ken Nomoto, M. Germana Sanna, Quinn Deveraux, Nicolas Schrantz
Publikováno v:
Molecular and Cellular Biology. 22:1754-1766
The antiapoptotic properties of the inhibitor of apoptosis (IAP) family of proteins have been linked to caspase inhibition. We have previously described an alternative mechanism of XIAP inhibition of apoptosis that depends on the selective activation